Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report)’s stock price shot up 7.8% during trading on Friday . The company traded as high as $0.20 and last traded at $0.19. 19,100 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Trading Up 7.8 %
The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.04. The business’s fifty day moving average is $0.19 and its 200 day moving average is $0.19.
Vyant Bio Company Profile
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
Read More
- Five stocks we like better than Vyant Bio
- CD Calculator: Certificate of Deposit Calculator
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Retail Stocks Investing, Explained
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Best Fintech Stocks for a Portfolio Boost
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
